Stock listing
Tectonic Therapeutic, Inc.
Selected listing: TECX · NASDAQ · USD · US
Tectonic Therapeutic, Inc. (NASDAQ:TECX), Commercial Services. Latest release Sep 29, 2026: Tectonic Therapeutic Announces Favorable Phase 1 Safety…
- Ticker
- NASDAQ:TECX
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD
About Tectonic Therapeutic, Inc.
The company focuses on developing innovative therapeutic solutions. Tectonic is committed to advancing healthcare through its research and development efforts.
Latest news from Tectonic Therapeutic, Inc.
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
September 29, 2026
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
September 28, 2026
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
September 3, 2026
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
August 6, 2026
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
June 9, 2026
Research Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. company profile
View the public company page for Tectonic Therapeutic, Inc. on 6ix.
Tectonic Therapeutic, Inc. news
Read company news and market updates connected to Tectonic Therapeutic, Inc..
Tectonic Therapeutic, Inc. investor events
Find investor webinars, events, and replay context for Tectonic Therapeutic, Inc..